Filing Impact
Filing Sentiment
Form Type
144
Fate Therapeutic
Aug 14, 2025
[SCHEDULE 13G/A] Fate Therapeutics, Inc. SEC Filing
Aug 12, 2025
[8-K] Fate Therapeutics, Inc. Reports Material Event
Aug 4, 2025
[144] Fate Therapeutics, Inc. SEC Filing
132.63M
113.36M
1.71%
78.72%
8.09%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
SAN DIEGO